Business
IMPLANET Receives FDA Clearance in the United States for the 3D Cage Range – Swingo™
BORDEAUX, France & BOSTON, March 03, 2026--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Swingo™ anterior cervical cage.
About this update from Implanet Sa
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1749,"height":653,"url":"https://media.zenfs.com/en/business-wire.com/759aa12d8f5d0e58009cbb066150ecbb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/G2F2.XzfwPBCoeD.9GGHsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM1ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/759aa12d8f5d0e58009cbb066150ecbb","width":960,"height":358},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/NotfghOSjNnhXVP7iozfBg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04OTY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/759aa12d8f5d0e58009cbb066150ecbb","width":1200,"height":448}},"lazy":false},{"type":"text","content":"BORDEAUX, France & BOSTON, March 03, 2026--(BUSINESS WIRE)--Regulatory News:","length":80,"tagName":"p"},{"type":"text","content":"IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Swingo™ anterior cervical cage.","length":335,"tagName":"p"},{"type":"text","content":"Developed through the work of a dedicated development group established in 2024 with a panel of international surgeons, the Swingo™ cage range features a broad portfolio of implant sizes with a design tailored to vertebral anatomy, ensuring improved control of interbody fusion. These titanium implants, manufactured using 3D printing technology, can be used for all types of procedures, regardless of the surgical approach chosen by the surgeon. A dedicated next-generation instrumentation range is included in this clearance and is designed to enhance patient safety while reducing surgical time.","length":598,"tagName":"p"},{"type":"text","content":"Ludovic Lastennet, CEO of IMPLANET, stated: "This new clearance marks an important milestone for IMPLANET. In the short term, combined with JSS (posterior fusion system), it will enable us to offer a comprehensive range of implants dedicated to spinal fusion in the United States, our priority market. The potential synergies created by our expanded product portfolio fully support our strategy to strengthen our presence in the U.S. This re...